Category: Functional services
Oversight Monitoring Successes A biopharmaceutical company engaged Catalyst Flex to provide appropriate and impartial oversight monitoring for several studies. Such services can help to prevent a sponsor from receiving findings during U.S. Food and Drug Administration (FDA) audits and in particular any Form FDA 483. Read Now 
Embracing Innovation and Collaboration in Clinical Data Science Attending PHUSE US Connect 2025 PHUSE US Connect 2025 was a remarkable event that brought Read Now 
The Role of Company Culture in Functional Service Provider (FSP) Partnerships Pharmaceutical and clinical research sponsors (clients) have long outsourced clinical development work, utilizing both full-service Read Now 
Driving Efficiencies in Clinical Trials Catalyst Flex at SCOPE 2025 This year, I attended the SCOPE 2025 conference with key Read Now 
A View of the Joint Clinical Assessment (JCA) Process An out-of-the-box solution to navigate regulation effectively The Joint Clinical Assessment (JCA) is a pivotal Read Now 
Partnering with Functional Service Providers How culture drives success Consultants across industries suggest that a better corporate culture — one Read Now 
Medical Writing and Functional Services Takeaways from ISPOR Europe 2024 An energetic team of Catalyst Flex medical writers—including me—conquered the Read Now 
ISPOR Europe 2024: Cutting-edge Insights and Medical Writing Expertise ISPOR Europe 2024 Poster Presentations The Catalyst Flex medical writing team was honored to have Read Now 
Project Success Expertise: Amy Hall Meet a Catalyst Flex Expert Welcome to Catalyst Flex Experts, a series celebrating our experts Read Now 
Functional Service Providers Are Central to Clinical Research Outsourcing and Operations Takeaways from the OCT NE Conference in Boston While at the Outsourcing Read Now